• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-脱氧-2-氟-β-糖基氟化物对大鼠体内β-葡萄糖苷酶和β-甘露糖苷酶活性的抑制作用以及体内和体外活性的恢复

In vivo inhibition of beta-glucosidase and beta-mannosidase activity in rats by 2-deoxy-2-fluoro-beta-glycosyl fluorides and recovery of activity in vivo and in vitro.

作者信息

McCarter J D, Adam M J, Hartman N G, Withers S G

机构信息

Department of Chemistry, University of British Columbia, Vancouver, Canada.

出版信息

Biochem J. 1994 Jul 15;301 ( Pt 2)(Pt 2):343-8. doi: 10.1042/bj3010343.

DOI:10.1042/bj3010343
PMID:8042975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1137085/
Abstract

2-Deoxy-2-fluoro-beta-glucosyl and -beta-mannosyl fluorides administered to rats in a single dose (10 mg/kg) inhibited beta-glucosidase and beta-mannosidase activity respectively after 1 h in brain, spleen, liver and kidney tissues. This inhibition, presumably caused by accumulation of 2-deoxy-2-fluoroglycosyl-enzyme intermediates, indicates that intact 2-deoxy-2-fluoroglycosyl fluorides are distributed to these organs and, in the case of brain, that they cross the blood/brain barrier. beta-Glucosidase activity recovered completely or partially in brain, spleen, liver and kidney by 20-48 h. beta-Mannosidase activity partially recovered in all tissues by 48 h. beta-Galactosidase activity in brain and kidney was not significantly affected by administration of either the gluco or manno compounds at this dosage, indicating that these inhibitors are directed towards specific glycosidases. Observation of similar relatively rapid rates of beta-glycosidase re-activation in vivo and in tissue homogenates in vitro at 37 degrees C suggests that hydrolysis or transglycosylation of 2-deoxy-2-fluoroglycosyl-enzymes, not protein synthesis, are the primary mechanisms involved in the recovery of glycosidase activity inhibited by this class of compounds in vivo.

摘要

以单剂量(10毫克/千克)给大鼠注射2-脱氧-2-氟-β-葡萄糖苷氟化物和2-脱氧-2-氟-β-甘露糖苷氟化物后,1小时后在脑、脾、肝和肾组织中分别抑制了β-葡萄糖苷酶和β-甘露糖苷酶的活性。这种抑制作用可能是由2-脱氧-2-氟糖基-酶中间体的积累引起的,这表明完整的2-脱氧-2-氟糖基氟化物分布到了这些器官,就脑而言,它们穿过了血脑屏障。β-葡萄糖苷酶活性在20-48小时内在脑、脾、肝和肾中完全或部分恢复。β-甘露糖苷酶活性在48小时内在所有组织中部分恢复。在这个剂量下,给大鼠注射葡萄糖或甘露糖化合物对脑和肾中的β-半乳糖苷酶活性没有显著影响,这表明这些抑制剂针对的是特定的糖苷酶。在37摄氏度下,体内和体外组织匀浆中β-糖苷酶重新激活的相对快速速率相似,这表明2-脱氧-2-氟糖基-酶的水解或转糖基化作用而非蛋白质合成是这类化合物在体内抑制的糖苷酶活性恢复的主要机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cce/1137085/36123f493d98/biochemj00083-0041-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cce/1137085/d71e6305e677/biochemj00083-0040-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cce/1137085/36123f493d98/biochemj00083-0041-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cce/1137085/d71e6305e677/biochemj00083-0040-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cce/1137085/36123f493d98/biochemj00083-0041-a.jpg

相似文献

1
In vivo inhibition of beta-glucosidase and beta-mannosidase activity in rats by 2-deoxy-2-fluoro-beta-glycosyl fluorides and recovery of activity in vivo and in vitro.2-脱氧-2-氟-β-糖基氟化物对大鼠体内β-葡萄糖苷酶和β-甘露糖苷酶活性的抑制作用以及体内和体外活性的恢复
Biochem J. 1994 Jul 15;301 ( Pt 2)(Pt 2):343-8. doi: 10.1042/bj3010343.
2
Synthesis of 5-amino-5-deoxy-D-mannopyranose and 1,5-dideoxy-1,5-imino-D-mannitol, and inhibition of alpha- and beta-D-mannosidases.5-氨基-5-脱氧-D-甘露吡喃糖和1,5-二脱氧-1,5-亚氨基-D-甘露糖醇的合成以及α-和β-D-甘露糖苷酶的抑制作用
Carbohydr Res. 1984 May 15;128(1):61-72. doi: 10.1016/0008-6215(84)85084-3.
3
The structural basis of the inhibition of human alpha-mannosidases by azafuranose analogues of mannose.甘露糖氮杂呋喃糖类似物对人α-甘露糖苷酶抑制作用的结构基础
Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):743-9. doi: 10.1042/bj2900743.
4
Inactivation of a beta-glucosidase through the accumulation of a stable 2-deoxy-2-fluoro-alpha-D-glucopyranosyl-enzyme intermediate: a detailed investigation.通过稳定的2-脱氧-2-氟-α-D-吡喃葡萄糖基酶中间体的积累使β-葡萄糖苷酶失活:详细研究
Biochemistry. 1992 Oct 20;31(41):9970-8. doi: 10.1021/bi00156a016.
5
Synthesis and conformation of 5-thio-D-glucal, an inhibitor of glycosidases.糖苷酶抑制剂5-硫代-D-葡糖醛的合成与构象
Carbohydr Res. 1983 Feb 16;113(1):166-71. doi: 10.1016/0008-6215(83)88230-5.
6
Studies on the constituents of Broussonetia species. III. Two new pyrrolidine alkaloids, broussonetines G and H, as inhibitors of glycosidase, from Broussonetia kazinoki Sieb.构树属植物的成分研究。III. 来自小构树的两种新的吡咯烷生物碱,构树碱G和H,作为糖苷酶抑制剂
Chem Pharm Bull (Tokyo). 1998 Jun;46(6):1048-50. doi: 10.1248/cpb.46.1048.
7
Carbohydrate contents, and glycosidase and glycosyl transferase activities in tissues from streptozotocin diabetic mice.链脲佐菌素诱导的糖尿病小鼠组织中的碳水化合物含量、糖苷酶和糖基转移酶活性
Comp Biochem Physiol B. 1985;80(3):629-32. doi: 10.1016/0305-0491(85)90303-7.
8
Biological properties of D- and L-1-deoxyazasugars.D-和L-1-脱氧氮杂糖的生物学特性。
J Med Chem. 2005 Mar 24;48(6):2036-44. doi: 10.1021/jm0495881.
9
Influence of ethanol on the activity of glycosidases in rats exposed to cadmium (Cd2+).乙醇对镉(Cd2+)暴露大鼠体内糖苷酶活性的影响。
Acta Biochim Pol. 1995;42(3):297-9.
10
The structural basis of the inhibition of human glycosidases by castanospermine analogues.栗精胺类似物对人糖苷酶抑制作用的结构基础。
Biochem J. 1990 Jul 1;269(1):227-31. doi: 10.1042/bj2690227.

引用本文的文献

1
Drug Discovery Based on Fluorine-Containing Glycomimetics.基于含氟糖模拟物的药物发现。
Molecules. 2023 Sep 15;28(18):6641. doi: 10.3390/molecules28186641.
2
Lipid-mimicking phosphorus-based glycosidase inactivators as pharmacological chaperones for the treatment of Gaucher's disease.脂质模拟磷基糖苷酶失活剂作为治疗戈谢病的药理伴侣分子
Chem Sci. 2021 Sep 20;12(41):13909-13913. doi: 10.1039/d1sc03831a. eCollection 2021 Oct 27.
3
Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT.使用正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)对水解酶进行分子成像

本文引用的文献

1
THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE.葡萄糖脑苷脂的代谢。I. 从脾脏组织中分离纯化一种葡萄糖脑苷脂裂解酶及其性质
J Biol Chem. 1965 Jan;240:39-43.
2
Caprine beta-mannosidosis. Inherited deficiency of beta-D-mannosidase.山羊β-甘露糖苷贮积症。β-D-甘露糖苷酶遗传性缺乏。
J Biol Chem. 1981 May 25;256(10):5185-8.
3
Evidence for two distinct forms of mammalian beta-mannosidase.哺乳动物β-甘露糖苷酶两种不同形式的证据。
Mol Imaging. 2017 Jan-Dec;16:1536012117717852. doi: 10.1177/1536012117717852.
4
Imaging of enzyme replacement therapy using PET.使用正电子发射断层扫描成像技术进行酶替代疗法的影像学研究。
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10842-7. doi: 10.1073/pnas.1003247107. Epub 2010 Jun 1.
J Biol Chem. 1982 Apr 10;257(7):3369-71.
4
Specific inactivation of lysosomal glycosidases in living fibroblasts by the corresponding glycosylmethyl-p-nitrophenyltriazenes.通过相应的糖基甲基对硝基苯基三氮烯对活成纤维细胞中溶酶体糖苷酶进行特异性失活。
Biochem J. 1980 May 15;188(2):337-43. doi: 10.1042/bj1880337.
5
[Studies on the action mechanism of glycoside splitting anzymes, I. Presentation and properties of specific inhibitors].[糖苷裂解酶作用机制的研究,I. 特异性抑制剂的介绍与性质]
Hoppe Seylers Z Physiol Chem. 1966;345(4):197-214.
6
The abnormalities of lysosomal enzymes in mucopolysacc- haridoses.黏多糖贮积症中溶酶体酶的异常。
Eur J Biochem. 1968 Dec;7(1):34-44. doi: 10.1111/j.1432-1033.1968.tb19570.x.
7
Goat liver beta-mannosidases: molecular properties, inhibition and inactivation of the lysosomal and nonlysosomal forms.山羊肝脏β-甘露糖苷酶:溶酶体和非溶酶体形式的分子特性、抑制作用及失活
Enzyme. 1985;34(2):75-82. doi: 10.1159/000469366.
8
Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.[11C]氯吉兰和[11C]-L-司来吉兰在小鼠体内的选择性、不可逆结合:利用正电子发射断层扫描测量脑内功能性单胺氧化酶活性的潜力。
Biochem Pharmacol. 1985 Sep 1;34(17):3207-10. doi: 10.1016/0006-2952(85)90173-x.
9
2-Deoxy-2-fluoro-D-glycosyl fluorides. A new class of specific mechanism-based glycosidase inhibitors.2-脱氧-2-氟-D-糖基氟化物。一类新型的基于特定机制的糖苷酶抑制剂。
J Biol Chem. 1988 Jun 15;263(17):7929-32.
10
Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.溴代棒曲霉素环氧化物和溴代棒曲霉素F对小牛肝脏胞质β-葡萄糖苷酶的活性位点定向抑制作用。
Arch Biochem Biophys. 1988 Jan;260(1):437-42. doi: 10.1016/0003-9861(88)90467-5.